December 03, 2018, Unilever announced its successful acquisition of 81.98% stake in GlaxoSmithKline (GSK) Bangladesh Ltd from Setfirst, making it the largest transaction in the history of capital market in Bangladesh. Under the acquisition, Unilever got the ownership of GSK’s iconic Health Food & Drinks (HFD) portfolio brands including Horlicks, Boost, and Glaxose-D. If these products were completely new to Unilever Bangladesh Ltd., what would necessary steps need to be taken in ‘Memorandum of Association (MOA)’ before acquisition? What if Unilever did not take any steps in MOA but complete acquisition?